the Robert Koch Institute
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue Andrew Zinin Lead Editor When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic.
Pancreatic cancer: New drug extends lives but isn't a cure
Pancreatic cancer: New drug extends lives but isn't a cure June 8, 2026Pancreatic cancer is notoriously difficult to treat — and in many cases leads to death just months after diagnosis. So it is no surprise that this headline created a stir: In a recent study, a new drug, daraxonrasib, was able to double the survival time of patients with pancreatic cancer. Compared with patients who underwent chemotherapy, those treated with daraxonrasib not only lived longer, but also reported a better...
Common plastics soak up ballistic impacts thanks to a cross-linking molecule
Common plastics soak up ballistic impacts thanks to a cross-linking molecule Sadie Harley Scientific Editor Robert Egan Associate Editor With help from a novel cross-linking molecule, MIT chemists have shown they can substantially improve the ballistic impact resistance of common polymers, including polystyrene and a type of rubber used to make shoe soles. Polystyrene is a hard, glassy polymer that is used to make many types of plastic containers, such as bottles and mugs, as well as...